ARCHIVES

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006